Rezolute, Inc. (RZLT)
3.08
-0.16
(-4.94%)
USD |
NASDAQ |
May 19, 15:38
Rezolute Research and Development Expense (Quarterly) : 11.41M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| XOMA Royalty Corp. | 0.049M |
| SELLAS Life Sciences Group, Inc. | 5.129M |
| ADMA Biologics, Inc. | 2.597M |
| Krystal Biotech, Inc. | 13.81M |